138 related articles for article (PubMed ID: 17416607)
1. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.
Ye Y; Lin Y; Perez-Polo R; Huang MH; Hughes MG; McAdoo DJ; Manickavasagam S; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H813-8. PubMed ID: 17416607
[TBL] [Abstract][Full Text] [Related]
2. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
Manickavasagam S; Ye Y; Lin Y; Perez-Polo RJ; Huang MH; Lui CY; Hughes MG; McAdoo DJ; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2007 Oct; 21(5):321-30. PubMed ID: 17620005
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
4. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.
Atar S; Ye Y; Lin Y; Freeberg SY; Nishi SP; Rosanio S; Huang MH; Uretsky BF; Perez-Polo JR; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1960-8. PubMed ID: 16339820
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
[TBL] [Abstract][Full Text] [Related]
7. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
[TBL] [Abstract][Full Text] [Related]
8. Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin.
Ye Y; Long B; Qian J; Perez-Polo JR; Birnbaum Y
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):391-9. PubMed ID: 20640495
[TBL] [Abstract][Full Text] [Related]
9. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.
Merla R; Ye Y; Lin Y; Manickavasagam S; Huang MH; Perez-Polo RJ; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1918-28. PubMed ID: 17616749
[TBL] [Abstract][Full Text] [Related]
10. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
Ye Y; Abu Said GH; Lin Y; Manickavasagam S; Hughes MG; McAdoo DJ; Perez-Polo RJ; Birnbaum Y
Cardiovasc Drugs Ther; 2008 Aug; 22(4):275-82. PubMed ID: 18327703
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
Fan Y; Yang S; Cao Y; Huang Y
Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
[TBL] [Abstract][Full Text] [Related]
12. Regular dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury: is it time to revisit PARIS?
Figueredo VM; Okusa C; Kaneda K; Inamura Y; Miyamae M
Int J Cardiol; 2014 Oct; 176(3):822-7. PubMed ID: 25156855
[TBL] [Abstract][Full Text] [Related]
13. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
[TBL] [Abstract][Full Text] [Related]
14. Evaluation cardioprotective effects of atorvastatin in rats by real time myocardial contrast echocardiography.
Filusch A; Buss S; Hardt S; Katus HA; Kuecherer HF; Hansen A
Echocardiography; 2008 Oct; 25(9):974-81. PubMed ID: 18771549
[TBL] [Abstract][Full Text] [Related]
15. Reduction of infarct size by short-term pretreatment with atorvastatin.
Birnbaum Y; Ashitkov T; Uretsky BF; Ballinger S; Motamedi M
Cardiovasc Drugs Ther; 2003 Jan; 17(1):25-30. PubMed ID: 12843684
[TBL] [Abstract][Full Text] [Related]
16. [Effect of atorvastatin on eNOS synthesis in organs of aging rats with myocardial ischemia-reperfusion].
Zhang J; Wang H; Ye P
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1708-12. PubMed ID: 23268394
[TBL] [Abstract][Full Text] [Related]
17. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?
Mensah K; Mocanu MM; Yellon DM
J Am Coll Cardiol; 2005 Apr; 45(8):1287-91. PubMed ID: 15837263
[TBL] [Abstract][Full Text] [Related]
18. Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection.
Suzuki K; Miura T; Miki T; Tsuchida A; Shimamoto K
J Cardiovasc Pharmacol; 1998 Jan; 31(1):1-9. PubMed ID: 9456270
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats.
Fan Y; Yang S; Zhang X; Cao Y; Huang Y
Clin Exp Pharmacol Physiol; 2012 Nov; 39(11):938-43. PubMed ID: 23106693
[TBL] [Abstract][Full Text] [Related]
20. [Cardioprotective effects of atorvastatin preconditioning via iNOS upregulation in a rabbit ischemia/reperfusion model].
Zhou Y; Chen MH; Liu JH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1041-5. PubMed ID: 18269828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
